Skip to content

I recently interviewed a panel of our senior investment professionals to discuss the implications of President Trump's first 100 days in office, the impact of tariffs, and the resulting market volatility. The panelists included: Jennifer Johnston, Director of Research, Municipal Bonds, Franklin Templeton Fixed Income; Jeff Schulze, CFA, Head of Economic and Market Strategy, ClearBridge Investments; and Jonathan Curtis, Chief Investment Officer, Portfolio Manager, Franklin Equity Group. They provided insights into the resilience of the US economy, the challenges and opportunities in the tech sector, and the broader economic and market trends. This summary will delve into the key topics they analyzed.

Resilience of the US economy

In our panelists’ view, the US economy continues to be resilient. Despite recent challenges, the labor market remains healthy. The drop in initial jobless claims to 215,000 on April 17, 2025, is a historically low figure given the size of the labor force. This indicates that a significant portion of the workforce remains employed, and labor income, a crucial factor in consumption, remains strong. Additionally, while consumer confidence has declined, actual consumer spending has been broad-based and robust. This suggests to us that US consumers are in a good position to continue their consumption patterns.

Risks to US “exceptionalism”

A combination of factors led to a recent, simultaneous decline in US stock valuations, fixed income rates and the US dollar. Forced liquidations and a reversal of foreign investment in US assets have put pressure on Treasury yields and the US dollar. This de-risking follows years of overaccumulation of US assets. We also believe the US dollar has been overvalued for the past three to five years and we’ve expected some adjustment to it for quite a while. Additionally, the market had been reacting to the possibility of President Trump removing Federal Reserve (Fed) Chair Jerome Powell, which Trump later said was not his intention. Fed independence is viewed as crucial for US capital markets, and any threat to it could be highly disruptive.

If the US economy experiences stagflation, we believe value stocks would look favorable, as they have tended to perform well in higher-inflation and lower-growth environments. Historically, sectors like energy, materials and health care have also done well during stagflationary periods. Investing in commodities, precious metals (especially gold) and commodity-producing countries can provide additional diversification.

Trump’s next 100 days

In our opinion, the Trump administration has a high tolerance for equity market pain and is focused on resetting the economy, which includes bringing manufacturing back to the United States. It extended the tariff adoption by 90 days and is not providing many signals on negotiations. While the administration is less concerned about equity markets, it is closely monitoring the 10-year Treasury yield. This is because rates above 5% would make financing the government as well as capital investments in manufacturing more difficult. It's also worth remembering the forthcoming positive aspects for the United States economy of Trump’s agenda, such as deregulation and corporate tax cuts, especially incentives for capital investments.

Equity market outlook

We expect the S&P 500 Index is likely to be range-bound between recent lows and around 5400 in the short term, with a potential recession being the key risk factor. Historical data shows that market declines during recessions can be modest, and the current selloff has already reached those levels. Thus, we believe the market has priced in much of the negativity, which may present opportunities for long-term investors.

Impact of funding cuts on the health care sector

The Trump administration’s latest cuts to health care research funding are more severe than the initial reductions and could negatively impact the health care sector. We are concerned about who could step in to fill the gap, as venture capitalists are less likely to fund such speculative, early-stage research. Large endowments and foundations like the Gates Foundation might help, but the amounts needed are substantial. Despite the challenges, the sector remains defensive, with people continuing to need medical care and innovations—like genomics, biotech and artificial intelligence (AI)—reducing health care costs and improving productivity. In our analysis, this resilience and ongoing innovation presents potential opportunities for equity investors to find mispriced companies that can navigate the current uncertainty.

Impact of tariffs and regulatory actions on the technology sector

At the start of the year, there was high optimism in the tech sector. However, the introduction of tariffs (and subsequent pauses) have led to declining business sentiment and uncertainty in cost structures, especially for companies with supply chains in Asia. Ongoing legal cases against tech giants like Google have also contributed further to the uncertain environment. Despite these challenges, we believe a couple of growth themes remail largely intact. There is still significant investment in AI from major companies such as Google and Amazon. We believe the Magnificent Seven (Alphabet, Amazon, Apple, Meta, Microsoft, Nvidia and Tesla) remain strong in fundamentals and innovation. Additionally, there is continued demand for AI applications from firms. In our analysis, the productivity gains from AI will likely be profound, and the United States is the leader in this area.

Municipal bond market and local governments

Leading up to the US presidential election, there was a noticeable slowdown in municipal revenue growth. However, the municipal bond market has benefited significantly from the post-COVID stimulus and inflation, which have driven up sales and income taxes. These taxes are primary revenue sources for state and local governments, including transit districts, and have helped strengthen the credit spectrum for municipal bonds. Despite some sectors struggling more than others, the overall credit position for municipals looks strong, and the slower growth assumptions in fiscal year 2025 budgets are being outpaced. This robust positioning, combined with management policies that have been honed during challenging times, suggests to us that the market is well-prepared to weather a potential rise in inflation or a recession. Even with increased supply in the municipal market and some volatility, sectors across the board are ready to issue and build capital, though higher rates could slow this activity.

One sector of note is the education sector. The higher education market is divided, with strong institutions like Harvard and Stanford on one end and struggling small regional liberal arts schools on the other. Many private colleges have closed or merged over the past two years, an unprecedented trend. While concerns over funding for research grants at top institutions exist, we believe these schools are well-positioned to absorb such losses.

There has been some discussion of municipal bonds’ potential loss of their tax exemption, which could have far-reaching implications, including higher borrowing costs. However, the tax exemption for municipal bonds is crucial for funding infrastructure at a lower cost, and there is strong support in Congress to maintain it. While certain sectors like higher education, private-activity bonds and health care could be targeted, we think the overall municipal bond market is unlikely to lose its tax-exempt status.

We think there is more value in staying neutral on duration while adding value through credit risk, often by investing in longer maturities and lower-rated bonds. There are also opportunities to capitalize on retail investors’ panic during volatility, with opportunities across the yield curve, especially in high-grade bonds that have become cheaper.

Conclusion

Despite ongoing uncertainty and volatility in the equity and bond markets, we believe the current environment presents significant opportunities. The tech sector, particularly in AI, remains a strong area of growth, with US companies leading the way in innovation. We believe focusing on company fundamentals is crucial, as this approach can help navigate challenges and seek to take advantage of what we consider market mispricings.



Copyright ©2025. Franklin Templeton. All rights reserved.

This document is intended to be of general interest only. This document should not be construed as individual investment advice or offer or solicitation to buy, sell or hold any shares of fund. The information provided for any individual security mentioned is not a sufficient basis upon which to make an investment decision. Investments involves risks. Value of investments may go up as well as down and past performance is not an indicator or a guarantee of future performance. The investment returns are calculated on NAV to NAV basis, taking into account of reinvestments and capital gain or loss. The investment returns are denominated in stated currency, which may be a foreign currency other than USD and HKD (“other foreign currency”). US/HK dollar-based investors are therefore exposed to fluctuations in the US/HK dollar / other foreign currency exchange rate. Please refer to the offering documents for further details, including the risk factors.

The data, comments, opinions, estimates and other information contained herein may be subject to change without notice. There is no guarantee that an investment product will meet its objective and any forecasts expressed will be realized. Performance may also be affected by currency fluctuations. Reduced liquidity may have a negative impact on the price of the assets. Currency fluctuations may affect the value of overseas investments. Where an investment product invests in emerging markets, the risks can be greater than in developed markets. Where an investment product invests in derivative instruments, this entails specific risks that may increase the risk profile of the investment product. Where an investment product invests in a specific sector or geographical area, the returns may be more volatile than a more diversified investment product. Franklin Templeton accepts no liability whatsoever for any direct or indirect consequential loss arising from use of this document or any comment, opinion or estimate herein. This document may not be reproduced, distributed or published without prior written permission from Franklin Templeton.

Any share class with “(Hedged)” in its name will attempt to hedge the currency risk between the base currency of the Fund and the currency of the share class, although there can be no guarantee that it will be successful in doing so. In some cases, investors may be subject to additional risks.

Please contact your financial advisor if you are in doubt of any information contained herein.

For UCITS funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the UCITS Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 93a of the UCITS Directive.

For AIFMD funds only: In addition, a summary of investor rights is available from here. The fund(s)/ sub-fund(s) are notified for marketing in various regions under the AIFMD Directive. The fund(s)/ sub-fund(s) can terminate such notifications for any share class and/or sub-fund at any time by using the process contained in Article 32a of the AIFMD Directive.

For the avoidance of doubt, if you make a decision to invest, you will be buying units/shares in the fund(s)/ sub-fund(s) and will not be investing directly in the underlying assets of the fund(s)/ sub-fund(s).

This document is issued by Franklin Templeton Investments (Asia) Limited and has not been reviewed by the Securities and Futures Commission of Hong Kong.

Unless stated otherwise, all information is as of the date stated above. Source: Franklin Templeton.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.